Jonathan Leeman
@jonathan_leeman
Followers
182
Following
238
Media
0
Statuses
46
Radiation Oncologist at Dana Farber Cancer Institute/Brigham and Women’s Hospital, Harvard Medical School. Focus on prostate cancer and MRI guided radiation.
Boston, MA
Joined December 2019
🔔Education Opportunity for Patients with #ProstateCancer & Their Families 📆 5/17/24 8amEST (virtual) Here from experts discussing ✴️ Diet/Lifestyle 🚴♂️ ✴️ AI 🤖 ✴️ Biochemical Recurrence 📈 ✴️ Genetics 🧬 ✴️ Survivorship ☺️ Register for FREE! ✍🏽 Link: https://t.co/xkF4emlXiZ
1
6
12
🔬 Congrats to @LeeGraceMD & our MR-guided #RT team @BrighamWomens /@DanaFarber for our study on 5-fx stereotactic #MRI-guided adaptive #Radiotherapy for high-risk thoracic oligo-mets (19 ultra+7 central), now out in @RadiotherapyOn1. #Cancer #LCSM #radonc
1
6
23
Our top 5 articles from the week, with: @AlexSpiraMDPhD @JSabari @DasMillie11 @MNagasaka @tarasanftmd @jonathan_leeman 1. https://t.co/5bc446f6H8 2. https://t.co/vr6dnErS4p 3. https://t.co/1LVqOFGIcx 4. https://t.co/N02os9Ew12 5. https://t.co/WxDP9KsW0u
0
2
15
Exciting news! We're hiring for a new Director of GU Radiation Oncology @MSKCancerCenter. Big shoes to fill,but an awesome opportunity to run a large service with a lot of active research, trials,and technology. #radonc @MSK_RadOnc @ASTRO_org #medtwitter
https://t.co/QzPMBA080F
2
17
67
1/ Check out this preprint that describes how we developed and validated a new #AI-based biomarker that we are calling “FaceAge”, which uses a simple face #photo to predict outcomes in #cancer patients! https://t.co/Sp8Emop6eV
#oncology #AImedicine #FaceAge
medrxiv.org
Because humans age at different rates, a person’s physical appearance may yield insights into their biological age and physiological health more reliably than their chronological age. In medicine,...
2
7
23
🌟 @HElhalawaniMD and Dr Veena Venkatachalam treated 11 yr old Celeste with novel MR-LINAC https://t.co/QGajSPUM7A
0
5
19
In a new @JAMANetworkOpen study, @BenjaminKannMD & @DanaFarber researchers developed an AI model to diagnose muscle wasting, known as sarcopenia, using CT scans in patients with head and neck cancer, aiding timely interventions. Release here ➡️ https://t.co/VVE8i2OpAc
0
6
15
Join us Sept. 22 for the X-Ray-Guided Online Adaptive Radiotherapy Symposium in Dallas! This symposium will provide a full day of presentations and interactive sessions with leading experts in adaptive radiotherapy. For more info and registration: https://t.co/TmJDh7E1cs
1
5
18
New in #ProstateCancer research | This meta-analysis of prostate SBRT studies found a significant reduction in the risk of acute urinary and GI side effects with MR-guided daily adaptive SBRT compared to standard CT-guided SBRT. 🔗 https://t.co/pnMcVDCpyN
@jonathan_leeman
1
7
10
Happy to share our latest study. We validated our deep learning ENE algorithm in the context of the @eaonc E3311 HPV+OPC de-escalation trial. Congratulations and a huge thank you all the co-authors for their help on this large, multi-institutional effort. 1/x
NEW Research on screening for extranodal extension in HPV-associated oropharyngeal #carcinoma using a CT-based #DeepLearning algorithm in a randomised de-escalation trial. @BenjaminKannMD
@BarbaraBurtness @RobertFerrisMD Read it here: https://t.co/SXO71O6D8H
1
9
22
📢 CALL FOR PAPERS - We are inviting submissions to a collection on #cancer therapy #toxicity, guest edited by Drs. Raymond Mak (@Dr_RayMak), Miranda Fidler-Benaoudia (@MirandaFidlerB) & Lova Sun. Find out more: https://t.co/zzR62w9IUp
1
2
4
📢Pleased to announce the recipients of the inaugural ☢️Radiation Oncology Accelerator Awards 🥇🥇 intended to foster collaborations between @DanaFarber/@BrighamWomens & @MGHCancerCenter #radonc Incredibly deserving group of early-stage investigators 🔥👏 #teamscience
2
6
33
🆕Does PSA at time of salvage therapy after radical prostatectomy for prostate cancer matter? Tilki, D'Amico, and co-authors report multinational findings here: https://t.co/eW2WMbvGP7
0
11
22
@rweichselbaum @EvanThomas84 @radiopeppe @HenningWillers @BenjaminKannMD @SBRT_CR Here is the latest: do we need to consider histologic subtype for NSCLC in #radonc ? An editorial with @maraantonoff and Dr. Annikka Weissferdt of @MDAndersonNews
https://t.co/QSHFyRL0sz HT @jonathan_leeman
#lcsm #tssmn cc @ElliotServaisMD @BrendonStilesMD @JFreemanDaily
1
5
10
Abs#298 @ASCO #GU23 👉 https://t.co/vf91uFh79Y: In pts with localized #prostatecancer (T1-T2; Gleason ≤ 3 + 4; PSA ≤ 20 ng/mL) ➡️ radiation (SBRT) associated with better urinary continence & sexual bother but more bowel bother after 2 yrs vs surgery @urotoday @PCFnews @Uromigos
6
85
154
I asked ChatGPT to give me 22 common regrets people have on their deathbeds The results were eye-openers:
116
1K
5K
Pleased to share the primary endpoint results of the randomized phase III MIRAGE trial evaluating whether aggressive margin reduction with MRI-guidance leads to reduced toxicity in the context of prostate SBRT, out today in @JAMAOncology
https://t.co/5ZKElUR4uk (1/n)
jamanetwork.com
This randomized clinical trial assesses genitourinary toxic effects after magnetic resonance imaging (MRI)–guided vs computed tomography (CT)–guided stereotactic body radiotherapy for prostate cancer.
20
106
238
The tradition of MSKCC TY class of 2014 meeting at ASTRO continues! Missing in action is @SanjayAnejaMD. This group of amazing people continues to do unbelievable things. Proud to call them friends and colleagues. #ASTRO22 #RadOnc @sophia_kamran @jonathan_leeman
0
6
25
Now in press: First ever real-time MR images of the radiation beam due to radiation chemistry. Read more here https://t.co/7kc1VJUSbC
@AAPMHQ #MRinRT #medphys
2
10
36